Works matching IS 16613791 AND DT 2024 AND VI 19 AND IP 1

Results: 12

Front & Back Matter.

Published in:: Breast Care, 2024, v. 19, n. 1, p. 1, doi. 10.1159/000537955
Publication type:: Article

PharmaNews.

Published in:: Breast Care, 2024, v. 19, n. 1, p. 84, doi. 10.1159/000537702
Publication type:: Article

Interview ABC7: Bridging the Gap.

Published in:

2024

By:

Wuerstlein, Rachel;
Cardoso, Maria-João;
Ribeiro, Joana M.;
Haidinger, Renate;
Müller, Volkmar;
Lambertini, Matteo;
Schumacher-Wulf, Eva

Publication type:

Interview

Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting

Published in:

Breast Care, 2024, v. 19, n. 1, p. 49, doi. 10.1159/000535135

By:

Decker, Thomas;
Zaiss, Matthias;
Klein, Dunja;
Hahn, Antje;
Hagen, Volker;
La Rosée, Paul;
Liersch, Rüdiger;
Wolff, Thomas;
Niemeier, Beate;
Hillebrand, Larissa E.;
Lennartz, Carolin;
Chiabudini, Marco;
Bengsch, Fee;
Indorf, Martin;
Marschner, Norbert

Publication type:

Article

The Factors Influencing Shoulder Mobility Disorders in Patients after Radical Breast Cancer Surgery: A Cross-Sectional Study.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 43, doi. 10.1159/000535063

By:

Zhang, Xin;
Wang, Chao;
Fan, Jialin;
Murakami, Shinichiro;
Xie, Hualong;
Huo, Ming

Publication type:

Article

Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2− Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 34, doi. 10.1159/000534634

By:

Ziegler, Cordula;
Sotlar, Karl;
Hofmann, Daniel Maria;
Kolben, Thomas;
Harbeck, Nadia;
Würstlein, Rachel

Publication type:

Article

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 73, doi. 10.1159/000534367

By:

Riecke, Kerstin;
Steinhilper, Lisa;
Von Bülow, Charlotte;
Schwarz, Dorothee;
Burandt, Eike;
Striefler, Jana Käthe;
Müller, Volkmar;
Schmalfeldt, Barbara;
Witzel, Isabell

Publication type:

Article

Budget Impact of the Oncotype DX Breast Recurrence Score<sup>®</sup> Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 27, doi. 10.1159/000534096

By:

Lux, Michael Patrick;
Minartz, Christof;
Müller-Huesmann, Harald;
Sandor, Marianar Felicia;
Radeck-Knorre, Sabine;
Neubauer, Aljoscha Steffen

Publication type:

Article

Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 10, doi. 10.1159/000533902

By:

Pixberg, Constantin;
Schulze, Markus;
Buschhorn, Lars;
Suppelna, Jan Philip;
Mock, Andreas;
Hlevnjak, Mario;
Heublein, Sabine;
Schumacher-Wulf, Eva;
Schneeweiss, Andreas

Publication type:

Article

Strict versus Liberal Use of Sentinel Node Biopsy in Breast Cancer Surgery: Any Clinical Outcome Differences? A 20-Year Clinical Experience.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 18, doi. 10.1159/000533731

By:

Barco, Israel;
García-Font, Marc;
García-Fdez, Antonio;
Fraile, Manel;
Vallejo, Elena;
Vidal, MCarmen;
González, Sonia;
González, Clarisa;
Beatriz Mitru, Claudia;
Porta, Oriol;
Chabrera Sanz, Carolina

Publication type:

Article

Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 62, doi. 10.1159/000533673

By:

Elfgen, Constanze;
Varga, Zsuzsanna;
Breitling, Katrin;
Pauli, Eliane;
Schwegler-Guggemos, Daniela;
Kampmann, Gert;
Kubik-Huch, Rahel A.;
Leo, Cornelia;
Lepori, Domenico;
Sonnenschein, Martin;
Tausch, Christoph;
Schrading, Simone

Publication type:

Article

Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study.

Published in:

Breast Care, 2024, v. 19, n. 1, p. 1, doi. 10.1159/000533657

By:

Harbeck, Nadia;
Wrobel, Denise;
Zaiss, Matthias;
Terhaag, Jürgen;
Guth, Dagmar;
Distelrath, Andrea;
Zahn, Mark-Oliver;
Würstlein, Rachel;
Lorenz, Andreas;
Bartsch, Rupert;
Breitenstein, Urs;
Schwitter, Michael;
Balic, Marija;
Jackisch, Christian;
Müller, Volkmar;
Rinnerthaler, Gabriel;
Schmidt, Marcus;
Zaman, Khalil;
Schinköthe, Timo;
Resch, Anna

Publication type:

Article